Legacy Healthcare Properties (LRP)

Legacy Healthcare Properties

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:LRP

1 2 3 4 Next >>

Date	Time	Source	Headline	Symbol	Company
13/04/2011	20:30	Edgar (US Regulatory)	Withdrawal of Registration Statement (RW)	NYSE:LRP	Legacy Healthcare Properties
05/10/2010	11:21	Edgar (US Regulatory)	Securities Registration: Real Estate Company (S-11/A)	NYSE:LRP	Legacy Healthcare Properties
16/09/2010	22:30	Edgar (US Regulatory)	Securities Registration: Real Estate Company (S-11/A)	NYSE:LRP	Legacy Healthcare Properties
21/07/2008	20:24	PR Newswire (US)	/C O R R E C T I O N from Source -- Lorus Therapeutics Inc./	NYSE:LRP
21/07/2008	12:30	PR Newswire (US)	Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008	NYSE:LRP
16/07/2008	13:12	PR Newswire (US)	Lorus Therapeutics Receives $600 Thousand From Escrow Account	NYSE:LRP
09/07/2008	13:00	PR Newswire (US)	Lorus Therapeutics Provides an Update on Progress in Virulizin(R) Development Program	NYSE:LRP
02/07/2008	14:00	PR Newswire (US)	Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with	NYSE:LRP
23/06/2008	12:30	PR Newswire (US)	Lorus Therapeutics announces that the European Medicines Agency (EMEA) has granted the orphan drug designation to LOR-2040 for t	NYSE:LRP
06/05/2008	21:22	PR Newswire (US)	AMEX Accepts Lorus' Plan to Meet AMEX's Continued Listing Standards	NYSE:LRP
05/05/2008	12:30	PR Newswire (US)	Lorus Therapeutics Strengthens Its Senior Management Team Through Internal Promotions	NYSE:LRP
22/04/2008	13:30	PR Newswire (US)	Lorus initiates development program exploring novel route of administration for LOR-2040	NYSE:LRP
16/04/2008	13:30	PR Newswire (US)	Lorus Therapeutics presents new findings for the anticancer drugs LOR-253 and LOR-2040	NYSE:LRP
09/04/2008	03:04	PR Newswire (US)	Lorus Therapeutics Announces Exclusive Multinational License Agreement with Zoticon Bioventures for Virulizin(R)	NYSE:LRP
22/01/2008	23:17	PR Newswire (US)	Lorus Therapeutics Appoints Peter Korth as Chief Financial Officer	NYSE:LRP
06/11/2007	12:30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw Annual Healthcare Conference	NYSE:LRP
20/09/2007	03:23	PR Newswire (US)	Lorus Therapeutics announces election of three new Directors and appoints a new Chairman	NYSE:LRP
29/08/2007	13:30	PR Newswire (US)	Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia	NYSE:LRP
23/07/2007	23:48	PR Newswire (US)	Lorus Therapeutics Announces the Appointment of a New Member of the Board of Directors	NYSE:LRP
11/07/2007	01:04	PR Newswire (US)	Lorus Therapeutics completes reorganization resulting in non dilutive financing	NYSE:LRP
05/07/2007	22:39	PR Newswire (US)	Lorus Therapeutics announces revised closing date for proposed plan of arrangement	NYSE:LRP
19/06/2007	14:30	PR Newswire (US)	Lorus Therapeutics announces the initiation of a clinical trial of GTI-2040 in acute leukemia and myelodysplastic syndrome	NYSE:LRP
14/05/2007	14:30	PR Newswire (US)	Lorus announces presentation of corporate overview at the Acumen Biofin Rodman & Renshaw 4th Annual Global Healthcare Conference	NYSE:LRP
02/05/2007	03:59	PR Newswire (US)	Lorus Therapeutics announces reorganization resulting in approximately $7,800,000 of non-dilutive financing	NYSE:LRP
19/04/2007	14:30	PR Newswire (US)	Lorus Therapeutics reports third quarter results for fiscal year 2007	NYSE:LRP
17/04/2007	14:30	PR Newswire (US)	Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Confe	NYSE:LRP
01/03/2007	13:00	PR Newswire (US)	Lorus Therapeutics Announces a Key Scientific Publication on Therapeutic siRNA in Cancer Therapy	NYSE:LRP
29/12/2006	12:00	PR Newswire (US)	Lorus Therapeutics reports second quarter results for fiscal year 2007	NYSE:LRP
06/11/2006	15:04	PR Newswire (US)	Lorus announces presentation of corporate overview at the Rodman and Renshaw 8th Annual Healthcare Conference	NYSE:LRP
01/11/2006	12:00	PR Newswire (US)	Lorus Therapeutics announces presentation on GTI-2040 uptake by tumor cells in acute myeloid leukemia	NYSE:LRP